Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development and Validation of RP-HPLC Method for Dissolution Drug Release of Dimethyl Fumarate Delayed Release Capsules

Development and Validation of RP-HPLC Method for Dissolution Drug Release of Dimethyl Fumarate... Abstract The objective of the current study was to develop and validate a short, economical, accurate, precise RP-HPLC method for drug release profiles of dimethyl fumarate delayed release capsules with avoiding acidic media degradation while performing the dissolution testing. The RP-HPLC method was developed by using liquid chromatography (waters 2695 with PDA detector) with XBridge C18 column using isocratic elution with a flow rate of 1.2 mL/min and detector wavelength of 223 nm. The mobile phase consists of 0.1% of ortho-phosphoric acid in water: acetonitrile (50:50% v/v) and runtime of 4 mins. In-vitro drug release study was designed by using USP type II apparatus with 0.1N HCl for 120 minutes followed by drug release profiles of 10, 20, 30 and 45 minutes with phosphate buffer pH: 6.8. The developed method was validated as per ICH guidelines. Good linearity and accuracy were achieved in the range of 0.1-120% of the nominal sample concentration. The similarity factor of (f2) 80 ≥ 50% indicates similarity between two dissolution profiles with less variation in drug release and the predicted method was accurate and precise. To improve the quantification of drug release, which is unstable in physiological dissolution medium of 0.1N HCl, was achieved by addition of suitable diluent in sample preparation. The intended drug release profiles method published here will support the pharmaceutical industries for quick quantitation of DMF in formulation development, routine analysis and stability studies of dimethyl fumarate drug product without compromise in quality attributes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analytical Chemistry Letters Taylor & Francis

Development and Validation of RP-HPLC Method for Dissolution Drug Release of Dimethyl Fumarate Delayed Release Capsules

Download PDF

Development and Validation of RP-HPLC Method for Dissolution Drug Release of Dimethyl Fumarate Delayed Release Capsules

Abstract

Abstract The objective of the current study was to develop and validate a short, economical, accurate, precise RP-HPLC method for drug release profiles of dimethyl fumarate delayed release capsules with avoiding acidic media degradation while performing the dissolution testing. The RP-HPLC method was developed by using liquid chromatography (waters 2695 with PDA detector) with XBridge C18 column using isocratic elution with a flow rate of 1.2 mL/min and detector wavelength of 223 nm. The...
Loading next page...
 
/lp/taylor-francis/development-and-validation-of-rp-hplc-method-for-dissolution-drug-bfgnm6bIdl
Publisher
Taylor & Francis
Copyright
© 2021 Har Krishan Bhalla & Sons
ISSN
2230-7532
eISSN
2229-7928
DOI
10.1080/22297928.2021.1914723
Publisher site
See Article on Publisher Site

Abstract

Abstract The objective of the current study was to develop and validate a short, economical, accurate, precise RP-HPLC method for drug release profiles of dimethyl fumarate delayed release capsules with avoiding acidic media degradation while performing the dissolution testing. The RP-HPLC method was developed by using liquid chromatography (waters 2695 with PDA detector) with XBridge C18 column using isocratic elution with a flow rate of 1.2 mL/min and detector wavelength of 223 nm. The mobile phase consists of 0.1% of ortho-phosphoric acid in water: acetonitrile (50:50% v/v) and runtime of 4 mins. In-vitro drug release study was designed by using USP type II apparatus with 0.1N HCl for 120 minutes followed by drug release profiles of 10, 20, 30 and 45 minutes with phosphate buffer pH: 6.8. The developed method was validated as per ICH guidelines. Good linearity and accuracy were achieved in the range of 0.1-120% of the nominal sample concentration. The similarity factor of (f2) 80 ≥ 50% indicates similarity between two dissolution profiles with less variation in drug release and the predicted method was accurate and precise. To improve the quantification of drug release, which is unstable in physiological dissolution medium of 0.1N HCl, was achieved by addition of suitable diluent in sample preparation. The intended drug release profiles method published here will support the pharmaceutical industries for quick quantitation of DMF in formulation development, routine analysis and stability studies of dimethyl fumarate drug product without compromise in quality attributes.

Journal

Analytical Chemistry Letters – Taylor & Francis

Published: May 4, 2021

Keywords: Dimethyl fumarate; Reverse-phase liquid chromatography (RP-HPLC); Drug release; pH: 6.8 phosphate buffer; Method validation

References

  • A multi-purpose RP-HPLC method development & validation of dimethyl fumarate drug substance and drug product: a concise review
  • Development and validation of RP-HPLC method for determination of related substances of dimethyl fumarate drug product
  • Stability indicating RP-HPLC assay method for estimation of dimethyl fumarate in bulk and capsules
  • Development and validation of a stability- indicating RP-HPLC method for the identification, determination of related substances and assay of dimethyl fumarate in drug substance
  • Stability indicating new-uplc method for determination of dimethyl fumarate in their pure and capsule dosage form
  • In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer
  • Determination of the purity of dimethy l fumarate by UV spectrophotometry
  • Determination of Dimethyl Fumarate Purity by UV Spectrophotometry
  • Electrohydrodimerization Reactions: II. Rotating Ring- Disk Electrode, Voltammetric and Coulometric Studies of Dimethyl Fumarate, Cinnamonitrile, and Fumaronitrile
  • Development and validation of analytical method for simultaneous estimation of dimethyl fumarate and dimenhydrinate in tablet dosage form
  • Development and Validation of Analytical Method for Simultaneous Estimation of Dimethyl Fumarate and Ondansetron
  • Determination of dimethyl fumarate (DMFu) in silica gel pouches using gas chromatography coupled ion trap mass spectrometry
  • Determination of dimethyl fumarate and other potential allergens in desiccant and antimould sachets
  • Gas- chromatography–mass spectrometry analysis of dimethyl fumarate in consumer products
  • Determination of dimethyl fumarate in leather and textiles by gas chromatography-tandem mass spectrometry with solid phase extraction
  • Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma: application to rat pharmacokinetic study
  • LC-MS/MS quantification of dimethyl fumarate and methyl hydrogen fumarate in rat blood using tiopronin as trapping reagent
  • Bioanalysis of monomethyl fumarate in human plasma by a sensitive and rapid LC-MS/MS method and its pharmacokinetic application
  • Bioanalytical method development and validation of monomethyl fumarate by liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study
  • Deter- mination of dimethyl fumarate in desiccant and antimould sachets by reversed-phase liquid chromatography
  • Determination of antimicrobial preservative dimethyl fumarate by high performance liquid chromatography
  • Inhibition of mold in bread by dimethyl fumarate
  • Determination of dimethyl fumarate and other fumaric and maleic acid diesters in desiccants and consumer products in Japan
  • Development and validation of RP-HPLC method for estimation of quetiapine fumarate in pharmaceutical formulations
  • Formulation and In-Vitro Evaluation of Novel Fixed Dose Triple Combinations of Antidiabetic and Anti-Hypertensive Drugs for Treatment of Hypertension in Diabetic Patients J
  • Formulation and Evaluation of Delayed Release Capsule of Dimethyl Fumarate with Novel Technology
  • Development and validation of HPLC method-a review
  • Chromatographic method validation: a review of current practices and procedures. I. General concepts and guidelines
  • Perspectives on method validation: importance of adequate method validation
  • Statistical evaluations of dissolution similarity
  • RES, an expert system for the set-up and interpretation of a ruggedness test in HPLC method validation: Part 1: The ruggedness test in HPLC method validation